Securian Asset Management Inc. Acquires 100 Shares of Axon Enterprise, Inc $AXON

Securian Asset Management Inc. grew its holdings in Axon Enterprise, Inc (NASDAQ:AXON) by 2.6% during the 2nd quarter, HoldingsChannel.com reports. The firm owned 3,905 shares of the biotechnology company’s stock after buying an additional 100 shares during the quarter. Securian Asset Management Inc.’s holdings in Axon Enterprise were worth $3,233,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Hemington Wealth Management raised its position in shares of Axon Enterprise by 70.8% in the second quarter. Hemington Wealth Management now owns 41 shares of the biotechnology company’s stock valued at $33,000 after purchasing an additional 17 shares during the period. TCTC Holdings LLC raised its position in shares of Axon Enterprise by 75.0% in the first quarter. TCTC Holdings LLC now owns 56 shares of the biotechnology company’s stock valued at $29,000 after purchasing an additional 24 shares during the period. Bartlett & CO. Wealth Management LLC raised its position in shares of Axon Enterprise by 132.0% in the first quarter. Bartlett & CO. Wealth Management LLC now owns 58 shares of the biotechnology company’s stock valued at $31,000 after purchasing an additional 33 shares during the period. Catalyst Capital Advisors LLC bought a new stake in shares of Axon Enterprise in the first quarter valued at approximately $32,000. Finally, Banque Transatlantique SA bought a new stake in shares of Axon Enterprise in the first quarter valued at approximately $31,000. Institutional investors own 79.08% of the company’s stock.

Insider Buying and Selling

In other news, CEO Patrick W. Smith sold 10,000 shares of the company’s stock in a transaction on Tuesday, October 7th. The shares were sold at an average price of $713.74, for a total value of $7,137,400.00. Following the completion of the sale, the chief executive officer owned 3,033,982 shares of the company’s stock, valued at approximately $2,165,474,312.68. This represents a 0.33% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CAO Jennifer H. Mak sold 77 shares of the company’s stock in a transaction on Monday, September 15th. The shares were sold at an average price of $760.00, for a total transaction of $58,520.00. Following the completion of the sale, the chief accounting officer directly owned 15,003 shares of the company’s stock, valued at $11,402,280. This trade represents a 0.51% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 59,932 shares of company stock worth $45,115,616 in the last ninety days. 5.70% of the stock is currently owned by insiders.

Analysts Set New Price Targets

Several analysts have recently issued reports on the stock. Weiss Ratings reissued a “hold (c)” rating on shares of Axon Enterprise in a research report on Wednesday, October 8th. Piper Sandler began coverage on shares of Axon Enterprise in a report on Tuesday, September 23rd. They set an “overweight” rating and a $893.00 target price on the stock. Northland Securities set a $800.00 target price on shares of Axon Enterprise in a report on Tuesday, August 5th. UBS Group reaffirmed a “neutral” rating and set a $840.00 target price (up previously from $820.00) on shares of Axon Enterprise in a report on Tuesday, August 5th. Finally, Bank of America upped their target price on shares of Axon Enterprise from $895.00 to $1,000.00 and gave the stock a “buy” rating in a report on Wednesday, August 6th. Fourteen analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $841.64.

Axon Enterprise Price Performance

Shares of NASDAQ:AXON opened at $707.04 on Wednesday. The company’s fifty day moving average price is $735.50 and its 200-day moving average price is $720.82. The firm has a market capitalization of $55.51 billion, a price-to-earnings ratio of 174.58, a PEG ratio of 26.53 and a beta of 1.41. Axon Enterprise, Inc has a one year low of $422.38 and a one year high of $885.91. The company has a debt-to-equity ratio of 0.63, a current ratio of 2.95 and a quick ratio of 2.71.

Axon Enterprise (NASDAQ:AXON) last issued its quarterly earnings results on Monday, August 4th. The biotechnology company reported $2.12 EPS for the quarter, topping analysts’ consensus estimates of $1.54 by $0.58. The firm had revenue of $668.54 million for the quarter, compared to analyst estimates of $641.77 million. Axon Enterprise had a net margin of 13.64% and a return on equity of 6.80%. The business’s revenue for the quarter was up 32.6% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.20 EPS. Axon Enterprise has set its FY 2025 guidance at EPS. On average, equities research analysts anticipate that Axon Enterprise, Inc will post 5.8 earnings per share for the current fiscal year.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.